96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04056442 (ClinicalTrials.gov)	July 7, 2019	13/8/2019	A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients	A Phase 2a, Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients	Steroid Dependent Crohn's Disease	Drug: Cannabidiol , synthetic form;Drug: Placebo	Stero Biotechs Ltd.	NULL	Recruiting	18 Years	N/A	All	28	Phase 2	Israel
2	NCT03467620 (ClinicalTrials.gov)	July 2018	5/3/2018	Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease	Oral Cannabidiol Capsule Usage as an Adjunct Therapy for Crohn's Disease: a Randomized, Placebo-controlled Study	Crohn Disease;Inflammatory Bowel Diseases;Cannabis	Drug: Cannabidiol;Drug: Placebo oral capsule	University of Illinois at Chicago	NULL	Withdrawn	18 Years	N/A	All	0	Phase 2/Phase 3	NULL
3	NCT01037322 (ClinicalTrials.gov)	January 2010	20/12/2009	Cannabidiol for Inflammatory Bowel Disease	Use of Cannabidiol for the Treatment of Inflammatory Bowel Disease	Crohn's Disease;Ulcerative Colitis	Drug: cannabidiol;Drug: placebo in drops	Meir Medical Center	NULL	Completed	20 Years	80 Years	Both	20	Phase 1/Phase 2	Israel